New Strategies for Lowering Low Density Lipoprotein Cholesterol for Cardiovascular Disease Prevention.
Sean Paul GaineRenato QuispeJaideep PatelErin D Michos
Published in: Current cardiovascular risk reports (2022)
Recently several novel LDL-C lowering medications have been approved. New therapeutic targets have been identified and present additional means of lowering LDL-C and other atherogenic compounds for patients who remain at high ASCVD risk.